More like making people sick is an economic externality. The worst case scenario is a class action lawsuit years after the C-suite has cashed out and whatever i

More like making people sick is an economic externality. The worst case scenario is a class action lawsuit years after the C-suite has cashed out and whatever income was left to the company coffers has already accrued gains from investments. Even then all one has to do is create a subsidiary to inherit the lawsuit and declare bankruptcy. I agree with you, though. I wouldn't be surprised at all if the people dumping chemicals everywhere are investing in oncology pharmaceuticals while they wait for the class actions. They know what they're causing.